camptothecin has been researched along with acetylglucosamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, DJ; Bansal, V; Kadari, A; Kulhari, H; Pooja, D; Sistla, R; Srinivasa Reddy, T | 1 |
1 other study(ies) available for camptothecin and acetylglucosamine
| Article | Year |
|---|---|
N-acetyl-d-glucosamine-conjugated PAMAM dendrimers as dual receptor-targeting nanocarriers for anticancer drug delivery.
Topics: A549 Cells; Acetylglucosamine; Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Dendrimers; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 2020 |